Raffaella Rossin, PhD

CSO and Founder

Dr. Rossin has a longstanding experience in radiolabeling and in vitro/in vivo testing of small molecules, antibodies and nanoparticles. From 2008-2015, Dr. Rossin worked as senior radiochemist at Philips Research, with primary focus on molecular imaging and drug delivery projects. In this role, she has been instrumental in developing the In Vivo Chemistry program that now forms the basis of Tagworks Pharmaceuticals. Prior to the position at Philips, she worked for 5 years at the School of Medicine of Washington University, St. Louis MO, as a post-doctoral research associate and as a research instructor in radiochemistry and nuclear imaging. Dr. Rossin obtained her MSc in organic chemistry and PhD in radiochemistry at the University of Padova, Italy. She has published over 50 peer-reviewed papers, reviews and book chapters and is a co-inventor on 9 patents.